IQVCongressional Stock Trades
IQVIA Holdings Inc.
Services-Commercial Physical & Biological Research
Congressional stock trades in IQVIA Holdings Inc. (IQV) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
6
Politicians Trading
3
Last Traded
Dec 29, 2025
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Markwayne MullinR | Jan 16, 2026 | Dec 29, 2025 | Buy | $15,001 - $50,000 | +17.31% |
| John BoozmanR | Nov 15, 2025 | Oct 2, 2025 | Sell | $1,001 - $15,000 | +30.38% |
| Robert BresnahanR | May 31, 2025 | May 15, 2025 | Sell | $1,001 - $15,000 | +89.72% |
| Robert BresnahanR | May 8, 2025 | Apr 8, 2025 | Buy | $15,001 - $50,000 | +84.39% |
| Robert BresnahanR | Mar 27, 2025 | Feb 25, 2025 | Sell | $1,001 - $15,000 | +39.51% |
| Markwayne MullinR | Feb 27, 2025 | Feb 13, 2025 | Buy | $15,001 - $50,000 | +35.89% |
Price History
About IQVIA Holdings Inc.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.